Grégory Behar
Chief Executive Officer at RECIPHARM AB (PUBL)
Net worth: 4 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Rinsch | M | - |
Amazentis SA
 Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 years |
| Marcus Chapman | M | 53 | 9 years | |
| Peter Brabeck-Letmathe | M | 79 |
Nestlé Health Science (Deutschland) GmbH
 Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a private company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | 27 years |
| Lukas Braunschweiler | M | 68 | 13 years | |
| Stephen Berenson | M | 63 | 5 years | |
| Julie Tay | F | 58 | 2 years | |
| Arnd Kaldowski | M | 57 | 7 years | |
| Paul Biondi | M | 54 | 4 years | |
| Marc Funk | M | 64 | 3 years | |
| Adrian Widmer | M | 56 | 4 years | |
| Carlo Tanzi | M | - | 9 years | |
| Birgit Conix | F | 58 | 3 years | |
| Willard Dere | M | 70 | 7 years | |
| Kurt Graves | M | 56 | 9 years | |
| Martin Hendrix | M | 56 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | 2 years |
| Jennifer Russo Wortman | F | - | 9 years | |
| Wolbrand Teunis C. van der Vis | M | 57 | 15 years | |
| Roland Diggelmann | M | 57 | 3 years | |
| Claire Fraser-Liggett | M | 68 | 1 years | |
| Thomas DesRosier | M | 69 | 8 years | |
| Lynn Bleil | F | 60 | 8 years | |
| Robert Spoerry | M | 69 | 21 years | |
| Pierre Landolt | M | 77 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 years |
| Cathy L. Kerzner | F | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Patrick Aebischer | M | 70 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 years |
| Stacy Seng | F | 60 | 10 years | |
| Dennis Ausiello | M | 78 | 9 years | |
| Katya Kruglova | F | 53 | 1 years | |
| Ludger Althoff | M | 60 | 5 years | |
| Ulrike Lemke | F | - | 3 years | |
| Luc Burgard | M | 43 | - | |
| Steven Klosk | M | 67 | 3 years | |
| Teresa Young | M | 57 | 4 years | |
| James Laur | M | 63 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | 4 years |
| David Ege | M | 50 | 4 years | |
| Eric Lohrer | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 9 years |
| Christiane Hanke-Harloff | M | - | - | |
| Mark Mckenna | M | 48 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Shabbir Mostafa | M | - | - | |
| Bernard Pluta | M | - | 9 years | |
| Kieran Chouhan | M | - | 5 years | |
| Maria Lacerca-Allen | M | 57 | 4 years | |
| Katarina Singer | F | - | - | |
| Christophe Lamacq | M | - | - | |
| Fiona Whyatt | F | - | - | |
| Brian Ray | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 1 years |
| Odile Rundquist | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 7 years |
| Christophe Fond | M | 58 | 7 years | |
| Douglas F. Wall | M | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Paul Bulcke | M | 69 |
Nestlé Health Science (Deutschland) GmbH
Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a private company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | - |
| Thomas Bernhardsgrütter | M | - | - | |
| Scott Glenn | M | 73 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Shlomo Melmed | M | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Erika Karin Elisabeth Henriksson | F | 43 | 3 years | |
| Mark Burgess Keatley | M | 67 | 3 years | |
| Henrik Giver | M | 35 | 3 years | |
| Thierry Lombard | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | - |
| Mark Royston Quick | M | 58 | 18 years | |
| Shierley Widjaja | F | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
| Kenth Berg | M | 65 | 27 years | |
| Richard Ridinger | M | 66 | 3 years | |
| Jean-François Hilaire | M | 60 | 9 years | |
| Victoria Carr-Brendel | M | 60 | 5 years | |
| Joaquim Beneyto Mascaro | M | - | 1 years | |
| William Sandborn | M | 61 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Noubar Afeyan | M | 60 | 12 years | |
| Paul R. Fonteyne | M | 63 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 9 years |
| Stephen Dilly | M | 64 | 4 years | |
| James M. Singh | M | 78 | 12 years | |
| Robert Connelly | M | 63 | 5 years | |
| Andrew Oxtoby | M | 50 | - | |
| David Berry | M | 47 | 5 years | |
| William Hinshaw | M | 55 | 5 years | |
| Shreeram Aradhye | M | 62 | 3 years | |
| Roger Pomerantz | M | 67 | 6 years | |
| Jayson Dallas | M | 56 | 2 years | |
| Paul Fehlner | M | 61 | 5 years | |
| Peter Hutt | M | 89 | 5 years | |
| Cristina Rondinone | M | 64 | 5 years | |
| Juan Aranols | M | 56 | - | |
| Heidy Abreu King-Jones | F | 41 | - | |
| Shane Maltbie | M | 42 | 4 years | |
| Lorence Kim | M | 49 | 6 years | |
| Stephen Hoge | M | 48 | 8 years | |
| Brett K. Haumann | M | 54 | - | |
| Paul Sekhri | M | 65 | 1 years | |
| Stacey Seltzer | F | 47 | 5 years | |
| Catherine Sohn | M | 71 | 4 years | |
| Meryl Zausner | F | 67 | 5 years | |
| Andreas Michalopoulos | M | 53 | - | |
| David N. Cook | M | 66 | 7 years | |
| Chip Baird | M | 52 | 5 years | |
| Beat W. Hess | M | 74 | 9 years | |
| Jason Fredette | M | - | - | |
| Michael Rosenblatt | M | 76 | 1 years | |
| Christopher Viehbacher | M | 64 | 4 years | |
| Kathryn Falberg | F | 63 | 5 years | |
| Mark McDade | M | 69 | 6 years | |
| David Arkowitz | M | 62 | 3 years | |
| Margaret Koziel | M | 64 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 53 | 53.00% |
| Switzerland | 28 | 28.00% |
| Sweden | 18 | 18.00% |
| Germany | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Grégory Behar
- Personal Network